Jerusalems SpliSense Secures Up to $13M to Advance Cystic Fibrosis Drug Trial
Jerusalem-based SpliSense has secured up to $13 million in funding from the Cystic Fibrosis Foundation to advance its Phase 2b clinical ...
Martes, 16 Hunyo 2026
Advance Cystic Fibrosis Drug Trial
Nabigasyon
- Negosyo
- Teknolohiya
- Pulitika
- Security
- Ekonomiya
- Kalusugan
- Mga Serbisyo
Pananalapi
Paglalakbay at Transportasyon
Teknolohiya at Utilities
Relihiyon at Kultura
Gobierno at Pampublikong Serbisyo
Impormasyon at mga Direktoryo